Aurinia Pharmaceuticals Inc

NASDAQ : AUPH

Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States. It offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company was incorporated in 1993 and is headquartered in Edmonton, Canada.

Information

Website
https://www.auriniapharma.com
Sector
Healthcare
Industry
Biotechnology
Type
Common Stock
Country
Canada

Price

USD 7.33

Symbol

AUPH

Type

Common Stock

Previous Close

 :

7.28

52 Week Range

 :

4.71 - 10.05

Volume

 :

918,100.00

Average Volume

 :

1,176,290.00

High

 :

7.44

Low

 :

7.22

Change

 :

0.05

Percent change (%)

 :

0.69

Stakeville

A Free-to-Play Trading Game. Sharpen your skills, trade stocks, and have fun!

Play Now
Getting Started
Get Your Free Account For Educational Purpose Knowledgebase
Legal
Cookie Policy Privacy Policy Terms & Conditions
Customer Service
Help Desk Support Stakeville Newsletter
Stay Connected
Contact Us Official Blog About Us
Disclaimer: Stakeville is a simulation trading game. All trades and stock prices are fictional and do not reflect real-world markets. This game is for entertainment purposes only and does not involve real financial transactions. Read more...